1. An open‐label phase I/II study of cyclophosphamide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed myeloma. (12th March 2015) Authors: Nishihori, Taiga; Baz, Rachid; Shain, Kenneth; Kim, Jongphil; Ochoa‐Bayona, Jose L.; Yue, Binglin; Sullivan, Daniel; Dalton, William; Alsina, Melissa Journal: European journal of haematology Issue: Volume 95:Number 5(2015:Nov.) Page Start: 426 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗